Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Amortizatization of Intangibles: 2017-2025

Historic Amortizatization of Intangibles for Cidara Therapeutics (CDTX) over the last 3 years, with Sep 2025 value amounting to $153,000.

  • Cidara Therapeutics' Amortizatization of Intangibles rose 665.00% to $153,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $205,000, marking a year-over-year increase of 210.61%. This contributed to the annual value of $79,000 for FY2024, which is 1216.67% up from last year.
  • Latest data reveals that Cidara Therapeutics reported Amortizatization of Intangibles of $153,000 as of Q3 2025, which was up 1,076.92% from $13,000 recorded in Q1 2025.
  • Over the past 5 years, Cidara Therapeutics' Amortizatization of Intangibles peaked at $153,000 during Q3 2025, and registered a low of $6,000 during Q4 2023.
  • For the 3-year period, Cidara Therapeutics' Amortizatization of Intangibles averaged around $35,857, with its median value being $20,000 (2024).
  • Data for Cidara Therapeutics' Amortizatization of Intangibles shows a peak YoY increase of 665.00% (in 2025) and a maximum YoY decrease of 35.00% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Cidara Therapeutics' Amortizatization of Intangibles stood at $6,000 in 2023, then spiked by 216.67% to $19,000 in 2024, then skyrocketed by 665.00% to $153,000 in 2025.
  • Its last three reported values are $153,000 in Q3 2025, $13,000 for Q1 2025, and $19,000 during Q4 2024.